Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis. (2023). European Journal of Medical and Health Sciences, 5(3), 1-2. https://doi.org/10.24018/ejmed.2023.5.3.1697